NCT03110393View on ClinicalTrials.gov

Ambu®AuraGain™ Versus I-gel® in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

September 6, 2017

Study Completion Date

September 6, 2017

Conditions
Obese
Interventions
DEVICE

Ambu AuraGain

Insert and intubation of an Ambu® AuraGain™ laryngeal mask

DEVICE

Intersurgical i-gel

Insert and intubation of an Intersurgical i-gel®

Trial Locations (1)

8008

Schulthess Klinik, Zurich

All Listed Sponsors
lead

Schulthess Klinik

OTHER

NCT03110393 - Ambu®AuraGain™ Versus I-gel® in Obese Patients | Biotech Hunter | Biotech Hunter